Blood clots form in response to signals from the lungs of cancer patients – not from other organ sites, as previously thought – according to a preclinical study by Weill Cornell Medicine, Memorial Sloan Kettering Cancer Center and University of California San Diego Health.
Weill Cornell Medicine has received a four-year, $1.4 million grant from the U.S. Department of Defense to investigate a new therapeutic approach for the most common form of kidney cancer.
Provost Kavita Bala and professors Anurag Agrawal and Dr. M. Virginia Pascual have been elected to the American Academy of Arts and Sciences, the academy announced on April 23.
Novo Nordisk’s top executive is testifying before senators today over the high prices of the company’s weight loss drug Wegovy and diabetes treatment Ozempic, as demand for both soars.
People with diabetes who were taking GLP-1 receptor agonist drugs had significantly lower rates of hospital readmission, wound reopening and hematoma after surgery, according to new study.
A cell protein previously believed only to provide a scaffolding for DNA has also been shown to directly influence DNA transcription into RNA – the first step of the process by which an organism’s genetic code expresses itself.
Weill Cornell Medicine researchers have found that removing protected class regulation from Medicare prescription drug policies could greatly reduce the United States' prescription drug spending, potentially saving $47 billion between 2011 and 2019.
The new platform, which provided 100% protection from influenza and COVID-19 in mouse models, could vastly improve vaccine administration and the efficacy of the current flu vaccine.
Two friends who bonded over shared concerns over their bone health have formulated a bioavailable calcium chew using milk protein from Finger Lakes dairy farms.
